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introduction: Tinnitus is the perception of noise in the absence of an external source 
and is considered by most authors as a multifactorial symptom. A systematic review 
concerning the association of tinnitus and systemic arterial hypertension retrieved sug-
gestions of a positive association, but the articles included failed to perform a detailed 
analysis on the theme.
Purpose: To analyze the presence of arterial hypertension in tinnitus and non-tinnitus 
patients, to analyze differences between tinnitus impact and psychoacoustic mea-
surements in hypertensive and normotensive patients, and to evaluate the association 
between the presence of tinnitus and the diverse antihypertensive drugs employed.
Materials and methods: This includes cross-sectional transversal study, comparing 
two groups of subjects (144 in the study group with tinnitus and 140 in the control 
group without tinnitus). Clinical, demographical, audiometrical, and psychoacoustics 
characteristics of the subjects were compared.
results: Hypertension prevalence in tinnitus subjects was 44.4% against 31.4% in 
subjects without tinnitus (p = 0.024). Positive associations with tinnitus were found with 
hypertension treatment with angiotensin-converting enzyme (ACE) inhibitors (p = 0.006), 
tiazidic diuretics (p <  0.0001), potassium-sparing diuretics (p =  0.016), and calcium 
channels blockers (p = 0.004).
conclusion: There is an association between tinnitus and arterial hypertension. This 
association is particularly strong in older patients. Hypertension treatment with diuretics, 
ACE inhibitors, and calcium channels blockers were more prevalent in tinnitus patients, 
suggesting that an eventual ototoxicity of these drugs may be involved in tinnitus patho-
physiology, a hypothesis that should be evaluated in further studies.
Keywords: tinnitus, arterial hypertension, hearing loss, cardiovascular diseases, hearing disorders
inTrODUcTiOn
Tinnitus is the perception of noise, which is not generated by external stimulus (1). It affects approxi-
mately 25% of the general population: one third on a frequent basis (2). Tinnitus may be classified as 
auditory and para-auditory tinnitus with the former representing the majority of cases, and the latter 
being subdivided into muscular and vascular tinnitus, sometimes referred as somatosounds (3).
According to the most recent trends of thought, tinnitus is considered a symptom which may 
have multiple causes, sometimes even in a single patient (4, 5). Noise exposure, metabolic and car-
diovascular disease, presbycusis, ototoxicity, and cranial and cervical trauma are the most frequently 
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considered causes of tinnitus (5, 6). Caffeine abuse, dietary fac-
tors, temporomandibular joint, and cervical disease have also 
been described as contributing factors (7–9).
Systemic arterial hypertension is a multifactorial clinical 
condition characterized by raised and sustained arterial pressure 
levels (10). It is defined as systolic levels equal or greater than 
140 mmHg and diastolic levels equal or greater than 90 mmHg 
(10). The prevalence in Brazil, similar to that in other countries, is 
estimated to be between 22.3 and 43.9% (32.5% average), raising 
to 50% between 60 and 69 years old and 75% for 70 years and older 
(10–12). The presence of comorbidities, such as diabetes mellitus 
and dyslipidemias, and habits, such as smoking, was demonstrated 
to increase complications risks (13). Arterial hypertension has been 
described as a possible cause of tinnitus since 1940s (14). Three 
principle mechanisms suspected of being involved are: damage to 
inner ear microcirculation (15), ototoxicity by antihypertension 
drugs (16), and perception of noise generated by blood vessels (3).
As related to inner ear microcirculation, the stria vascularis 
was demonstrated to be the main cochlear site damaged by arte-
rial hypertension (17). Sodium retention could also lead to an 
increase of extracellular fluid volume, including the perilymph 
(18), and the endocochlear potential being reduced in hyperten-
sive rats (19). Moreover, hypertension has been associated with a 
higher risk of hearing loss in brain ischemia (15) and also with a 
slower recovery in sudden hearing loss (20).
In considering ototoxicity, an extensive review cited diuretics, 
beta-blockers, angiotensin-conversing enzyme (ACE) inhibitors, 
angiotensin II receptors blockers, and calcium channels blockers 
as possible ototoxic medications (21). Furosemide’s ototoxicity is 
the most studied form, producing a quick and reversible decrease 
of the endocochlear potential (22).
As for vascular tinnitus, some studies cite hypertension as 
a causal factor, mainly when vascular abnormalities have been 
ruled out (3). An anatomopathological study demonstrated a 
high incidence of bony dehiscence of the carotid canal in the 
middle ear, which may affect the inner ear microcirculation and 
also generate vascular noises (23).
According to a systematic review, there is evidence of an 
association between tinnitus and arterial hypertension, but there 
is a lack of more comprehensive studies (24). The association is 
stronger in studies that analyzed the presence of arterial hyper-
tension in patients with tinnitus than in those which analyzed the 
presence of tinnitus in patients with arterial hypertension.
The main purpose of this study is to analyze the presence of arte-
rial hypertension in tinnitus and non-tinnitus patients. Secondary 
purposes are to analyze differences between tinnitus impact and 
psychoacoustic measurements in hypertensive and normotensive 
patients and to evaluate the association between the presence of 
tinnitus and the diverse antihypertensive drugs employed.
MaTerials anD MeThODs
This is a transversal case–control study in which individu-
als of 18  years of age or older with and without tinnitus were 
selected at the author’s ENT clinic from 2011 to 2014. The trial 
was approved by the Institutional Review Board (number 010/
CEP-FMV/2011). This study was carried out in accordance 
with the recommendations of the aforementioned Institutional 
Review Board with written informed consent from all subjects. 
All subjects gave written informed consent in accordance with 
the Declaration of Helsinki.
Two groups were created: the first included patients with tinni-
tus of at least 3 months duration and the second included patients 
without tinnitus (control). The control group was paired with the 
tinnitus group for gender, age, and race. The time of tinnitus onset as 
related to arterial hypertension onset was not an exclusion criteria. 
Patients from both groups were submitted to anamnesis (including 
demographics, comorbidities, and habits), otorhinolaryngological 
physical examination, and arterial pressure measurements with a 
calibrated sphygmomanometer (Erka Perfekt Aneroid, Germany), 
in order to exclude possible undiagnosed arterial hypertension. 
The criteria for blood pressure evaluation were those from the VII 
Joint National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure, U. S. Department of Health 
and Human Services, as previously described.
Patients allegedly normotensive with high blood pressure 
detected at the physical examination were excluded. Patients 
from both groups also underwent conventional pure tone and 
speech audiometry.
Tinnitus patients were questioned regarding their tinnitus 
characteristics (duration, type of sound, laterality, and periodic-
ity) and also classified their tinnitus according to a Visual Analog 
Scale (VAS), from 1 to 10 (for intensity and distress) and to the 
Brazilian Portuguese validated version of the Tinnitus Handicap 
Inventory (THI) (25). They also underwent psychoacoustic meas-
urements of their tinnitus – Pitch Matching (PM) and Minimum 
Masking Level (MML).
The sample size was determined after the analysis of the arte-
rial hypertension prevalence in a preliminary sample of tinnitus 
patients (n = 46) that was compared to the prevalence of arterial 
hypertension in the Brazilian general population, obtained from 
previous studies (10). The minimum number of individuals for 
each group was determined to be 140.
For whole sample analysis, the comparison of the variables 
between the tinnitus group and the control group was performed 
using the Mann–Whitney test for the numerical data and the chi-
square or the Fisher test for the categorical data. The Spearman 
coefficient was performed to analyze the association between the 
duration of arterial hypertension and the numerical audiometry 
measurements. The Cochran–Mantel–Haenszel was used to ana-
lyze the association between tinnitus and arterial hypertension 
adjusting for the presence of hearing loss. The significance level 
was established at 5%, and the statistical analysis was performed 
with the SAS statistical software, 6.11 version (SAS Institute, Inc., 
Cary, NC, USA).
resUlTs
The final sample was composed of 144 patients in the tinnitus 
group and 140 in the control group. The tinnitus group was then 
divided into two subgroups: one for patients with arterial hyper-
tension and the other without arterial hypertension.
The average age was 57.8 years of age for the tinnitus group 
and 58.6 for the control group. The averages of tinnitus duration, 
Table 2 | analysis of categorical variables (gender, age, race, and 
presence of arterial hypertension) according to the groups.
Variable category Tinnitus no Tinnitus p-Valuea
n % n %
Gender Male 62 43.1 65 46.4 0.57
Female 82 56.9 75 53.6
Age (years) ≤40 18 12.5 14 10.0 0.82
41–59 55 38.2 60 42.9
60–69 40 27.8 36 25.7
≥70 31 21.5 30 21.4
Race White 93 71.5 98 70.0 0.94
Brown 22 16.9 24 17.1
Black 15 11.5 18 12.9
Arterial 
Hypertension
Yes 64 44.4 44 31.4 0.024
No 80 55.6 96 68.6
Significant values in bold.
aχ2 or Fisher test.
Table 1 | analysis of the numerical variables (age, duration of arterial 
hypertension, and daily consumption of caffeine) according to the group.
Variable Tinnitus no tinnitus p-Value
n Median iQa n Median iQa
Age (years) 144 59 49–69 140 58 50–67 0.97
Arterial 
hypertension 
duration 
(months)
60 120 39–216 43 180 84–240 0.019
Caffeine  
(ml/day)
144 100 50–200 140 300 200–400 0.0001
Significant values in bold.
IQA, Interquartilic Amplitude: Q1–Q3.
Table 3 | Prevalence of hearing loss among tinnitus and non-tinnitus 
patients (χ2 test).
Variable category Tinnitus no Tinnitus p-Value
N (ears) % N (ears) %
Hearing 
loss
Yes 111 81.3 75 53.6 <0.0001
No 32 18.7 65 46.4
Table 4 | analysis of the categorical variable – antihypertensive drugs 
used according to the groups.
Variable category Tinnitus no tinnitus p-Value
n % n %
B-blocker Yes 19 13.2 21 15.0 0.66
No 125 86.8 119 85.0
ACEI Yes 23 16.0 8 5.7 0.006
No 121 84.0 132 94.3
ARB Yes 34 23.6 24 17.1 0.18
No 110 76.4 116 82.9
Loop 
diuretic
Yes 0 0.0 4 2.9 0.057
No 144 100.0 136 97.1
Thiazidic 
diuretic
Yes 29 20.1 8 5.7 <0.0001
No 115 79.9 132 94.3
K sparing 
diuretic
Yes 6 4.2 0 0.0 0.016
No 138 95.8 140 100.0
CCA Yes 13 9.0 2 1.4 0.004
No 131 91.0 138 98.6
χ-squared or Fisher tests.
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; 
CCA, calcium channel antagonist.
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VAS for intensity, VAS for distress, and THI scores for the tinnitus 
group were, respectively, 54.5 months–4.5 years, 5.45, 5.83, and 
41.7 points.
Although the duration of arterial hypertension was longer 
(average of 128.7 months–10.7 years) than the duration of tinnitus 
(average of 54.5 months), no statistically significant correlation 
was found, according to the Spearman coefficient. Considering 
the patients that could ascertain the duration of both arterial 
hypertension and tinnitus (n = 56), for 42 of them (75%) arterial 
hypertension preceded tinnitus.
Table  1 shows the comparison of numerical variables and 
Table 2 shows the categorical variables, the latter confirming the 
pairing by gender, age, and race. As shown in Table 2, arterial 
hypertension was more prevalent in tinnitus patients (p = 0.024), 
demonstrating an association of tinnitus and arterial hyperten-
sion. This association was not found when data were adjusted for 
the presence of hearing loss (p = 0.27, according to the Cochran–
Mantel–Haenszel test). Hearing loss was more frequent in the 
tinnitus group, as shown in Table 3, but there was no difference 
between the two groups as to the type of hearing loss or the shape 
of the audiogram curve. Sensorineural descendant was the most 
frequent curve in both groups (75% in the tinnitus patients group 
and 58% in the control group). Also, there was no difference in the 
speech recognition index of both groups (100% median in both).
The analysis of the antihypertensive drugs used in both groups 
is shown in Table 4.
The analysis of comorbidities and habits demonstrated that 
dyslipidemia was more frequent in the tinnitus group (p-value of 
0.003), while the presence of diabetes mellitus, hypothyroidism, 
noise exposure, caffeine consumption, and smoking was similar 
in both groups. When considering the coexistence of arterial 
hypertension and comorbidities and habits, the association of 
arterial hypertension and caffeine consumption greater than 
150 milliliters per day was more frequent in the tinnitus group 
(p < 0.0001).
Table 4 shows data about the antihypertensive drugs used in 
both groups.
Table  5 shows data from the numerical variables for the 
tinnitus’ patients subgroups, those with and without arterial 
hypertension.
There was no statistical difference between the two subgroups 
concerning gender and race. Diabetes mellitus and dyslipidemia 
were more frequent in the subgroup with tinnitus and arterial 
hypertension (p  =  0.017 and 0.02, respectively), while there 
were no differences concerning hypothyroidism, noise exposure, 
caffeine consumption, or smoking. Hearing loss was considered 
to be more prevalent in the subgroup with arterial hypertension 
(89.1%), although it was also frequent in the normotensive sub-
group (75%, p = 0.032). No differences concerning the type or 
curve were found.
Table 6 | analysis of the categorical variables (tinnitus clinical 
characteristics) according to the tinnitus’ patients’ subgroups (with and 
without arterial hypertension).
Variable category arterial 
hypertension 
subgroup
no arterial 
hypertension 
subgroup
p-Valuea
n % n %
Laterality RE 13 20.3 22 27.5 0.60
LE 15 23.4 14 17.5
Bilateral 32 50.0 41 51.3
Head 4 6.3 3 3.8
Instalation Sudden 33 55.0 33 42.9 0.0.16
Gradual 27 45.0 44 57.1
Periodicity Constant 45 70.3 55 69.6 0.93
Intermittent 19 29.7 24 30.4
aχ2 or Fisher test.
RE, right ear; LE, left ear.
Table 5 | analysis of the numerical variables (age, caffeine consumption, 
tinnitus duration, Visual analog scale, Tinnitus handicap inventory, Pitch 
Masking, and Minimum Masking level) according to the subgroups of 
tinnitus patients (with and without arterial hypertension).
Variable arterial  
hypertension subgroup
no arterial  
hypertension subgroup
p-Valuea
n Median iQa n Median iQa
Age 
(years)
64 66 57–72 80 52.5 43–65 0.0001
Caffeine 
(ml/day)
58 100 50–200 67 100 100–200 0.78
Tinnitus 
duration 
(months)
59 24 9–60 76 18 5.3–60 0.22
VAS 
volume 
(points)
63 5 3–7 80 6 4–8 0.37
VAS 
distress 
(points)
63 5 3–8 80 6 4–9 0.37
THI score 
(points)
63 40 18–70 80 38 16.5–61.5 0.75
PM RE 
(Hz)
40 4000 1000–8000 64 6000 2000–8000 0.58
PM LE 
(Hz)
45 4000 1500–8000 56 6000 3250–8000 0.27
MML RE 
(dB SL)
40 15 5–25 63 15 10–30 0.36
MML LE 
(dB SL)
44 15 5–29 55 15 5–25 0.48
Nineteen patients reported no caffeine consumption, nine patients could not estimate 
the duration of their tinnitus, and one patient could not report VAS and THI scores.
IQA, interquartilic amplitude: Q1–Q3.
Bold is to highlight the significant data.
aMann–Whitney test.
VAS, Visual Analog Scale; THI, Tinnitus Handicap Inventory; PM, Pitch Masking; 
MML, Minimum Masking Level; RE, right ear; LE, left ear; dB, decibel; dB SL, decibel 
Sensation Level.
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Table 6 shows the tinnitus characteristics in both subgroups.
The most frequently described types of tinnitus were wheezing, 
whistle, and insect with no differences between the subgroups. 
The presence of multiple types of sound in the same patient was 
more frequently found in the hypertensive subgroup (p = 0.014). 
The prevalence of vascular tinnitus was 6.3% in the hypertensive 
subgroup and 1.3% in the normotensive one (p =  0.12) with 
muscular tinnitus being found in only two cases, both being in 
normotensive patients.
No significant differences were found between the subgroups 
concerning the otolaryngologic exam, including evaluation of 
the temporomandibular joint. Finally, there was no correlation 
discovered between the duration of arterial hypertension and 
tinnitus according to the Spearman coefficient (p = 0.77).
DiscUssiOn
Association studies are key sources of information for the com-
prehension of how one disorder may affect another. A study on 
attempt to establish a correlation between arterial hypertension 
and tinnitus studies will help to elucidate characteristic in com-
mon that could be addressed in the diagnosis and therapeutic 
interventions. However, causal correlate studies would demand a 
plethora of different cases, including patients without tinnitus or 
arterial hypertension who were also free from other infirmities or 
habits which could be linked to tinnitus generation. Oftentimes, 
this elaborate type of study requires an extensive time period and 
patients with incredibly varied conditions.
A systematic review on this subject (24) argued that studies 
which have evaluated the prevalence of tinnitus among hyper-
tensive patients failed to demonstrate an association (26–29). 
However, data from this study, along with other studies (2, 30, 31), 
demonstrated an association between tinnitus and arterial hyper-
tension (hypertension prevalence in tinnitus patients =  44.4% 
against 31.4% in patients without tinnitus, p = 0.024).
The information above may lead one to infer that tinnitus 
could be a causal factor for hypertension, albeit it seems more 
reasonable to believe arterial hypertension is more a cofactor than 
a main cause of tinnitus.
Regarding hearing loss, the results are in conformity with 
prior studies, which found a high prevalence among tinnitus 
patients, as well as the higher prevalence of sensorineural pattern 
with descending configuration curves (2, 5).
Once hearing loss was added to (adjusted for) the statistical 
analysis, the association between tinnitus and arterial hyperten-
sion was no longer positive, suggesting that arterial hypertension 
may be a cause of hearing loss, which is related to most cases 
of tinnitus, as previously reported (1, 6). Having said so, if we 
think about tinnitus prevention, arterial hypertension may still 
be regarded as a possible important causal factor.
Arterial hypertension may affect the inner ear microcircula-
tion, and it is known that comorbidities, such as diabetes mellitus 
and dyslipidemia, may enhance vascular impairment due to 
hypertension (10). Although dyslipidemia was more prevalent in 
the tinnitus group, there was no difference concerning the con-
comitancy of arterial hypertension and dyslipidemia. Diabetes 
mellitus also affects the inner ear microcirculation, but it may 
also have direct metabolic effects on cochlea (4, 5, 20). There 
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was a statistical tendency in favor of a higher prevalence of the 
concomitancy of diabetes and hypertension in the tinnitus group. 
As for hypothyroidism, another metabolic disease frequently 
cited as related to tinnitus (6), no differences between the two 
groups were found, either as an isolated factor or in association 
with arterial hypertension. The comparison between the tin-
nitus subgroups (with and without hypertension) demonstrated 
that diabetes mellitus and dyslipidemia were more prevalent in 
hypertensive tinnitus patients, suggesting that these diseases 
may act synergically upon the generation, maintenance and/or 
aggravation of tinnitus.
The excessive consumption of caffeine is believed to have a 
negative impact on hypertension control (32), but its association 
with tinnitus has been doubted by recent studies (9, 33, 34). Data 
from this study failed to demonstrate any association between 
tinnitus and caffeine consumption. In fact, the concomitancy of 
hypertension and caffeine intake greater than 150 ml per day was 
more prevalent in the control group, which may reflect the wide-
spread patients’ concept that caffeine worsens tinnitus. Smoking, 
which is believed to worsen both tinnitus and hypertension, 
probably by impairing macro and microcirculation (10, 35), was 
more prevalent in the tinnitus group, either as an isolated factor 
or concomitant to hypertension.
Considering these findings, one might speculate that vascular 
changes, which may affect cochlear microcirculation, leading to 
hair cells damage and, consequently, tinnitus is probably a com-
mon pathophysiological scenario for many conditions, such as 
arterial hypertension, dyslipidemia, diabetes mellitus, smoking, 
and caffeine abuse. These conditions are not infrequently found 
in a single patient and may act sinergically, multiplying the dam-
age to the auditory system.
Although noise exposure is considered as one of the main 
causes of tinnitus (4, 6), data from this study failed to establish 
an association between noise exposure and tinnitus, either 
isolated or concomitant to hypertension. This finding should be 
considered with caution, being that the study was performed in 
an industrial city where many workers are exposed to industrial 
or recreational noise.
The average age of patients with tinnitus and arterial hyperten-
sion was significantly higher than the age of those in the group 
with tinnitus and no arterial hypertension. In the hypertension 
tinnitus subgroup most of the patients were 60  years or older, 
while the opposite was verified in the subgroup without hyper-
tension. Both tinnitus and arterial hypertension are more preva-
lent in the elderly (2, 10), but these findings may also be due to 
some synergistic action of presbycusis and arterial hypertension 
contributing to tinnitus generation and, eventually, aggravation.
The difference concerning arterial hypertension duration, 
which was significantly lower in the tinnitus group, may be due 
to a lack of proper control of blood pressure in the first years, 
which may lead to perfusion and reperfusion vascular events in 
the cochlea. More studies are needed to clarify these findings.
The median of the pitch masking was higher (6 kHz) in the 
subgroup without hypertension than when compared to the 
hypertension subgroup (4  kHz), although this difference was 
not statistically significant. Both measures are in agreement with 
most of the references, tinnitus ranging from 3 to 8 kHz, which 
corresponds to the usually most affected frequencies in hearing 
loss (36, 37). As for the MML, the averages of both subgroups were 
the same (15 dB SL), which is somewhat higher than the usually 
reported sensation level of 5–10 dB SL (37). No differences were 
demonstrated concerning the degree of intensity and distress due 
to tinnitus in both subgroups, considering the VAS and the THI.
The tinnitus’ characteristics were similar in both groups, 
including the type of sound perceived by the patients. The fact that 
multiple sounds’ tinnitus was more prevalent in the hypertensive 
patients may reflect the multicausality of tinnitus, hypertension 
being one of the possible factors involved.
Although the average duration of arterial hypertension was 
longer than the duration of tinnitus and for most of the patients 
the onset of hypertension preceded the onset of tinnitus, the 
methodology of this case–control does not allow the conclusion 
that hypertension is a causal factor for tinnitus.
The ototoxicity of many antihypertension medications has 
been well established, especially with diuretics (21, 22). Data 
from this study demonstrated that the use of ACE inhibitors, 
thiazidic diuretics, potassium-sparing diuretics, and calcium 
channels blockers was more prevalent in the tinnitus hypertensive 
patients than in the control group. These findings have a partial 
correspondence with prior studies (16) and, although they are 
not strong enough to justify a correlation between an eventual 
ototoxicity of these drugs and the presence of tinnitus (for 
example, multidrug therapy for hypertension is very frequent), it 
appears that further, more detailed studies on this subject should 
be performed.
cOnclUsiOn
There is an association between tinnitus and arterial hyperten-
sion. This association is particularly strong in older patients 
and cannot be dissociated from the hearing loss, which was also 
more prevalent among tinnitus patients. The use of thiazidic and 
potassium-sparing diuretics, ACE inhibitors, and calcium chan-
nels blockers was more prevalent in tinnitus patients.
The clinical and psychoacoustic characteristics of tinnitus in 
hypertensive and normotensive patients were similar, as well as 
tinnitus-related distress.
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